Cancer Drugs Bring in Most Pharma Revenue

According to Evaluate's calculations, oncology drugs reached $123.8b in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with $48.5b in sales. By 2024, cancer drug sales are expected to almost double to $236.6b